Efecto de la rosuvastatina sobre el infarto experimental en conejos normales e hipercolesterolémicos
作者： Laura Schreier , Regina Wikinski , Verónica Miksztowicz , Verónica D'annunzio , Nidia Basso
DOI:
关键词:
摘要: Resumen es: Es conocido que el pretratamiento con rosuvastatina disminuye tamano del infarto y mejora la disfuncion ventricular. Sin embargo, no existe evidenc...
参考文章(15)
Naranjan S. Dhalla, Harjot K. Saini, Amarjil S. Arneja, Role of cholesterol in cardiovascular dysfunction. Canadian Journal of Cardiology. ,vol. 20, pp. 333- 346 ,(2004)
Yasuko Kureishi, Zhengyu Luo, Ichiro Shiojima, Ann Bialik, David Fulton, David J. Lefer, William C. Sessa, Kenneth Walsh, The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals. Nature Medicine. ,vol. 6, pp. 1004- 1010 ,(2000) , 10.1038/79510
David Fulton, Jean-Philippe Gratton, Timothy J. McCabe, Jason Fontana, Yasushi Fujio, Kenneth Walsh, Thomas F. Franke, Andreas Papapetropoulos, William C. Sessa, Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature. ,vol. 399, pp. 597- 601 ,(1999) , 10.1038/21218
Mart??n Donato, Ver??nica DAnnunzio, Gabriela Berg, Germ??n Gonzalez, Laura Schreier, Celina Morales, Regina L. W Wikinski, Ricardo J Gelpi, Ischemic postconditioning reduces infarct size by activation of A1 receptors and K+(ATP) channels in both normal and hypercholesterolemic rabbits. Journal of Cardiovascular Pharmacology. ,vol. 49, pp. 287- 292 ,(2007) , 10.1097/FJC.0B013E31803C55FE
Robert M Bell, Derek M Yellon, Atorvastatin, administered at the onset of reperfusion, and independent oflipid lowering, protects the myocardiumby up-regulating a pro-survival pathway Journal of the American College of Cardiology. ,vol. 41, pp. 508- 515 ,(2003) , 10.1016/S0735-1097(02)02816-4
Yasuhiko Ikeda, Lindon H. Young, Allan M. Lefer, Rosuvastatin, a New HMG-CoA Reductase Inhibitor, Protects Ischemic Reperfused Myocardium in Normocholesterolemic Rats Journal of Cardiovascular Pharmacology. ,vol. 41, pp. 649- 656 ,(2003) , 10.1097/00005344-200304000-00019
P Golino, P R Maroko, T E Carew, Efficacy of platelet depletion in counteracting the detrimental effect of acute hypercholesterolemia on infarct size and the no-reflow phenomenon in rabbits undergoing coronary artery occlusion-reperfusion. Circulation. ,vol. 76, pp. 173- 180 ,(1987) , 10.1161/01.CIR.76.1.173
Justin C. MASON, Statins and their role in vascular protection. Clinical Science. ,vol. 105, pp. 251- 266 ,(2003) , 10.1042/CS20030148
David J. Maron, Sergio Fazio, MacRae F. Linton, Current Perspectives on Statins Circulation. ,vol. 101, pp. 207- 213 ,(2000) , 10.1161/01.CIR.101.2.207
P DINAPOLI, A TACCARDI, A GRILLI, M DELUTIIS, A BARSOTTI, M FELACO, R DECATERINA, Chronic treatment with rosuvastatin modulates nitric oxide synthase expression and reduces ischemia-reperfusion injury in rat hearts. Cardiovascular Research. ,vol. 66, pp. 462- 471 ,(2005) , 10.1016/J.CARDIORES.2005.02.008